Home >> Life Sciences >> Pharmaceuticals

African Trypanosomiasis Global Clinical Trials Review, H1, 2017

Published: Mar-2017 | Format: PDF | GlobalData | Number of pages: 36 | Code: MRS - 124494

African Trypanosomiasis Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “African Trypanosomiasis Global Clinical Trials Review, H1, 2017" provides an overview of African Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on African Trypanosomiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 9
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 10
Clinical Trials by G7 Countries: Proportion of African Trypanosomiasis to Infectious Disease Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in African Trypanosomiasis Therapeutics Clinical Trials 20
Prominent Drugs 21
Clinical Trial Profile Snapshots 22
Appendix 33
Abbreviations 33
Definitions 33
Research Methodology 34
Secondary Research 34
About GlobalData 35
Contact Us 35
Source 36

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

EMEA (Europe, Middle East and Africa) Epinephrine Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 118 | Code : MRS-201189 | 4480

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901 Read more

EMEA (Europe, Middle East and Africa) Chlorhexidine Gluconate Solution Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 116 | Code : MRS-201188 | 4480

Chlorhexidine Gluconate (CHG) Solution has been used in more than 60 different harmaceuticals and medical devices. Its wide application is due to its broad-spectrum efficacy, safety-profile and substantivity on the skin with low irritation. It has been found to possess a high level of antimicrobial activity and strong affinity for binding to skin and mucous membranes. Scope of the Report: This report focuses on the Chlorhexidine Gluconate Solution in EMEA market, covering Europe, Mid Read more

EMEA (Europe, Middle East and Africa) Guaifenesin (API) Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 120 | Code : MRS-201094 | 4480

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways. Scope of the Report: This report focuses on the Guaifenesin (API) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on Read more

Europe Travelers Vaccines Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Jan-2018 | Global Info Research | Pages : 117 | Code : MRS-201093 | 4480

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it late Read more

Europe Pharmaceutical Logistics Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Jan-2018 | Global Info Research | Pages : 119 | Code : MRS-201092 | 4480

Pharmaceutical Logistics is the logistics of pharmaceuticals, medical and surgical supplies, medical devices and equipment, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after s Read more

China Pneumococcal Vaccine Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Jan-2018 | Global Info Research | Pages : 115 | Code : MRS-200861 | 4480

"Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines. 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK). In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control)." Scope of the Report: This repo Read more

2017-2022 United States Head Lice Infestation Drug Market Report (Status and Outlook)

Jan-2018 | LPI (LP Information) | Pages : 113 | Code : MRS-198975 | 3360

In 2016, the Head Lice Infestation Drug market size was xx million in United States, and it will be xx million in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the top players include Bayer Omega Pharma Thornton and Ross Prestige Brands Perrigo Actavis Reckitt Benckier Tyratech Shionogi TecLabs Arborpharma Major Pharmaceuticals Logic Products Tianren ParaPRO Split by product types/cat Read more

2017-2022 North America Head Lice Infestation Drug Market Report

Jan-2018 | LPI (LP Information) | Pages : 113 | Code : MRS-198974 | 4660

In 2016, the North America Head Lice Infestation Drug market size was xx million and it will reach xx million in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Head Lice Infestation Drug in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering Bayer Omega Pharma Thornton and Ross Prestige Brands Perrigo Actavis Reckitt Benckier Tyratech Shionogi TecL Read more

2017-2022 India Head Lice Infestation Drug Market Report (Status and Outlook)

Jan-2018 | LPI (LP Information) | Pages : 113 | Code : MRS-198973 | 3360

In 2016, the Head Lice Infestation Drug market size was xx million in China, and it will be xx million in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include Bayer Omega Pharma Thornton and Ross Prestige Brands Perrigo Actavis Reckitt Benckier Tyratech Shionogi TecLabs Arborpharma Major Pharmaceuticals Logic Products Tianren ParaPRO Split by product types/category, covering Read more

2017-2022 Europe Top Countries Head Lice Infestation Drug Market Report

Jan-2018 | LPI (LP Information) | Pages : 113 | Code : MRS-198972 | 4660

In 2016, the Europe Head Lice Infestation Drug market size was xx million and it will reach xx million in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Head Lice Infestation Drug in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, covering Bayer Omega Pharma Thornton and Ross Prestige Brands Perrigo Actavis Reckitt Benckier Read more

Single User | $(USD)2500 View Pricing